PricingLoginNewsroom
Vol. II — No. 184Remarkable People · Exceptional CompaniesToday's Edition

humoral-immuno-oncology

(2)
AllCompaniesPeopleStoriesProducts
Legend
Nicholas Nicolaides Keeps Returning to the Same Tiny Question: What Is the Antibody Missing?
Founder · Executive · Scientist

Nicholas Nicolaides Keeps Returning to the Same Tiny Question: What Is the Antibody Missing?

He turned a lesson in genetic error correction into one biotech company, stayed after its $325 million sale, then began again with old collaborators and a new puzzle: why good antibodies sometimes go quiet.

nicholas-nicolaides · navrogenRead →
Company
The Cancer Drug Isn’t Broken. Navrogen Thinks the Tumor Is Blocking the Signal
Health

The Cancer Drug Isn’t Broken. Navrogen Thinks the Tumor Is Blocking the Signal

A tiny Pennsylvania biotech is betting that some antibody therapies fail for a surprisingly fixable reason: tumors throw molecular sand in the gears. Its answer is to redesign the antibody - or remove the sand.

biotechnology · cancer-therapyRead →